Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Κύριοι συγγραφείς: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
American Society for Microbiology
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
ανά: Chotsiri, P, κ.ά.
Έκδοση: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
ανά: Palang Chotsiri, κ.ά.
Έκδοση: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
ανά: Bergstrand, M, κ.ά.
Έκδοση: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
ανά: Myint, H, κ.ά.
Έκδοση: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)